ARCHITECT TSH REAGENT KIT
Report
- Report Number
- 3005094123-2023-00086
- Event Type
- Injury
- Date Received
- April 4, 2023
- Date of Event
- March 13, 2023
- Report Date
- May 18, 2023
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Product Code
- JLW
- UDI-DI
- 00380740014247
- PMA / PMN Number
- K983442
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
AN EVALUATION IS IN PROCESS. A FOLLOW UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.
THE EVALUATION OF COMPLAINT DATA FOR THE PRODUCT AND LIKELY CAUSE ARCHITECT TSH REAGENT LOT 48544UD00 IDENTIFIED NORMAL COMPLAINT ACTIVITY AND THERE ARE NO TRENDS FOR THE PRODUCT RELATED TO PATIENT RESULTS. NO CUSTOMER RETURNS WERE AVAILABLE FOR EVALUATION. INHOUSE TESTING OF REAGENT LOT 48544UD00 DETERMINED THAT THE ACCURACY PERFORMANCE IS NOT NEGATIVELY IMPACTED. MANUFACTURING DOCUMENTATION FOR THE LIKELY CAUSE LOT DID NOT IDENTIFY ANY ISSUES ASSOCIATED WITH THE COMPLAINT ISSUE. THE PERFORMANCE OF THE LIKELY CAUSE LOT WAS INVESTIGATED BY COMPLETING A REVIEW FOR NON-CONFORMANCES, POTENTIAL NON-CONFORMANCES AND DEVIATIONS RELATED TO THE LIKELY CAUSE LOT. THIS REVIEW DID NOT IDENTIFY ANY NON-CONFORMANCES, POTENTIAL NON-CONFORMANCES OR DEVIATIONS. A REVIEW OF LABELING CONCLUDED THAT THE ISSUE IS SUFFICIENTLY ADDRESSED. BASED ON OUR INVESTIGATION NO SYSTEMIC ISSUE OR PRODUCT DEFICIENCY OF THE ARCHITECT TSH REAGENT LOT 48544UD00 WAS IDENTIFIED. SEE MFR# SEE MFR# 3005094123-2023-00089-00 FOR THE OTHER LOT# SUBMISSION.
AN EVALUATION IS IN PROCESS. A FOLLOW UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. SEE MFR# SEE MFR# 3005094123-2023-00089-00 FOR THE OTHER LOT# SUBMISSIONSECTION B1 AND B2 UPDATED SECTION B5 UPDATED WITH ADDITIONAL INFORMATION/DATA SECTION H1 UPDATED TO SERIOUS INJURY SECTION H6. CHANGED HEALTH EFFECT IMPACT CODE TO F05
THE CUSTOMER REPORTED A FALSELY DECREASED ARCHITECT TSH RESULT ON A PATIENT. RESULTS PROVIDED: (B)(6) SID (B)(6) (LOT# 48544UD00) = 4.58, 1:10 DILUTION = 15.092 / 11.934 UIU/ML, COBAS = 18.2 NO UOM PROVIDED. NORMAL RANGE: (0.35-4.95 UIU/ML). NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
THE CUSTOMER REPORTED A FALSELY DECREASED ARCHITECT TSH RESULT ON A PRETERM NEWBORN PATIENT. RESULTS PROVIDED: (B)(6) 2023 SID (B)(6) ON LOT# (47474UD00) = 7.016, 1:10 DILUTION = 14.5 UIU/ML, COBAS = 18.62 (NO UOM PROVIDED). NEW SAMPLE, SAME PATIENT (B)(6) 2023 SID (B)(6) (LOT# 48544UD00) = 4.58, 1:10 DILUTION = 15.092 / 11.934 UIU/ML, COBAS = 18.2 (NO UOM PROVIDED).THE NEONATAL PRETERM INFANT WITH DOWN SYNDROME HAD A DELAY IN THYROID TREATMENT.
THE CUSTOMER REPORTED A FALSELY DECREASED ARCHITECT TSH RESULT ON A PRETERM NEWBORN PATIENT. RESULTS PROVIDED: (B)(6) 2023 SID (B)(6) ON LOT# (47474UD00) = 7.016, 1:10 DILUTION = 14.5 UIU/ML, COBAS = 18.62 (NO UOM PROVIDED). NEW SAMPLE, SAME PATIENT (B)(6) 2023 SID (B)(6) (LOT# 48544UD00) = 4.58, 1:10 DILUTION = 15.092 / 11.934 UIU/ML, COBAS = 18.2 (NO UOM PROVIDED). THE NEONATAL PRETERM INFANT WITH DOWN SYNDROME HAD A DELAY IN THYROID TREATMENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 392745 | ARCHITECT TSH REAGENT KIT | RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE | JLW | ABBOTT IRELAND DIAGNOSTICS DIVISION | 7K62-30 | 48544UD00 | 00380740014247 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown | Other | ARC I2000SR INST, 03M74-02, ISR50611| ARC I2000SR INST, 03M74-02, ISR50611| ARC I2000SR INST, 03M74-02, ISR50611 |